High-Risk Multiple Myeloma in 2026: Evolving Definitions and Therapeutic Options. Canadian Hematology Today, Toronto, Canada, v. 5, n. 1, p. 45–53, 2026. DOI: 10.58931/cht.2026.5187. Disponível em: https://canadianhematologytoday.com/article/view/5-1-Cowan_et_al. Acesso em: 10 jun. 2026.